Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.53%38.18B | 1.22%179.48B | 0.95%123.29B | 2.58%80.61B | 1.10%36.88B | 36.43%177.31B | 32.54%122.13B | 39.87%78.58B | 38.31%36.48B | 21.24%129.96B |
| Operating income | 1.22%179.48B | 2.58%80.61B | 36.43%177.31B | 39.87%78.58B | 21.24%129.96B | |||||
| Cost of sales | ---- | -2.25%-168.72B | ---- | -2.54%-75.06B | ---- | -38.05%-165B | ---- | -41.39%-73.2B | ---- | -18.53%-119.52B |
| Operating expenses | -2.25%-168.72B | -2.54%-75.06B | -38.05%-165B | -41.39%-73.2B | -18.53%-119.52B | |||||
| Gross profit | -14.35%1.99B | -12.56%10.76B | -6.32%8.49B | 3.05%5.54B | -7.35%2.32B | 17.90%12.3B | 14.68%9.06B | 22.01%5.38B | 23.59%2.51B | 64.31%10.43B |
| Selling expenses | ---- | 0.54%-1.88B | ---- | -15.50%-1.04B | ---- | -162.44%-1.89B | ---- | -211.09%-902.9M | ---- | -34.39%-719.58M |
| Administrative expenses | ---- | -3.30%-1.65B | ---- | -11.57%-887.5M | ---- | -23.98%-1.6B | ---- | -26.13%-795.48M | ---- | -4.31%-1.29B |
| Research and development expenses | ---- | 8.68%-4.46B | ---- | 9.78%-2.23B | ---- | -3.55%-4.89B | ---- | -0.57%-2.47B | ---- | -18.95%-4.72B |
| Profit from asset sales | ---- | ---42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | 227.15%55.81M | ---- | 1,111.90%43.61M | ---- | -75.71%-43.89M | ---- | 40.76%-4.31M | ---- | -682.27%-24.98M |
| -Other impairment is provision | ---- | 227.15%55.81M | ---- | 1,111.90%43.61M | ---- | -75.71%-43.89M | ---- | 40.76%-4.31M | ---- | -682.27%-24.98M |
| Special items of operating profit | ---- | 9.84%1.51B | ---- | -12.87%646.17M | ---- | 15.84%1.38B | ---- | 4.89%741.63M | ---- | -14.37%1.19B |
| Operating profit | -18.43%4.29B | 6.49%2.07B | 8.04%5.26B | 12.52%1.95B | 143.84%4.87B | |||||
| Financing cost | ---- | 28.90%-370.31M | ---- | 43.45%-174.93M | ---- | -176.15%-520.85M | ---- | -425.95%-309.34M | ---- | -222.24%-188.61M |
| Earning before tax | -17.28%3.92B | 15.94%1.9B | 1.27%4.74B | -2.04%1.64B | 141.47%4.68B | |||||
| Tax | ---- | 14.32%-406.77M | ---- | -41.29%-166.69M | ---- | 25.79%-474.78M | ---- | 23.46%-117.98M | ---- | -690.30%-639.77M |
| After-tax profit from continuing operations | -17.61%3.51B | 13.97%1.73B | 5.55%4.27B | 0.14%1.52B | 117.56%4.04B | |||||
| Earning after tax | -17.61%3.51B | 13.97%1.73B | 5.55%4.27B | 0.14%1.52B | 117.56%4.04B | |||||
| Profit attributable to shareholders | -95.53%27.83M | -17.61%3.51B | 2.40%3.14B | 13.97%1.73B | 1.92%622.12M | 5.55%4.27B | 0.64%3.06B | 0.14%1.52B | 33.01%610.41M | 117.56%4.04B |
| Basic earnings per share | -96.43%0.01 | -17.46%1.56 | 2.21%1.39 | 14.93%0.77 | 3.70%0.28 | 5.59%1.89 | 0.74%1.36 | 0.00%0.67 | 35.00%0.27 | 118.29%1.79 |
| Diluted earnings per share | -96.43%0.01 | -17.46%1.56 | 2.21%1.39 | 14.93%0.77 | 3.70%0.28 | 5.59%1.89 | 0.74%1.36 | 0.00%0.67 | 35.00%0.27 | 118.29%1.79 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.